| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.68B | +58.2% |
| R&D Expense | $197.0M | -1.5% |
| SG&A Expense | $442.0M | +47.8% |
| Pre-tax Income | $4.58B | +325.4% |
| Income Tax | $1.40B | +165.6% |
| Net Income | $3.35B | +234.2% |
| EPS (Basic) | $2.92 | +198.3% |
| EPS (Diluted) | $2.92 | +198.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.62B | +20.6% |
| Short-term Investments | $21.0M | -8.7% |
| Accounts Receivable | $1.06B | +43.9% |
| Current Assets | $12.28B | +63.4% |
| Total Assets | $56.35B | +1.5% |
| Current Liabilities | $7.54B | +25.8% |
| Long-term Debt | $8.48B | -4.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.36B | +130.3% |
| Investing Cash Flow | -$2.70B | -169.7% |
| Financing Cash Flow | -$2.95B | -84.2% |
| Total Liabilities |
| $26.24B |
| -0.2% |
| Stockholders' Equity | $29.93B | +3.1% |